Susceptibility of Clinical Isolates of Staphylococcus aureus to Ceftaroline
- 1 January 2021
- journal article
- research article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
Abstract
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.Keywords
This publication has 17 references indexed in Scilit:
- Comparative in-vitro activity of ceftaroline against Staphylococcus aureus isolates from IndiaJournal of Infection in Developing Countries, 2016
- In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance ProgramAntimicrobial Agents and Chemotherapy, 2015
- In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus isolatesIndian Journal of Medical Microbiology, 2015
- Missense Mutations in PBP2A Affecting Ceftaroline Susceptibility Detected in Epidemic Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clonotypes ST228 and ST247 in Western Switzerland Archived since 1998Antimicrobial Agents and Chemotherapy, 2015
- Estudio multicéntrico sobre la actividad in vitro de ceftarolina frente a Staphylococcus aureus aislados en EspañaEnfermedades Infecciosas y Microbiología Clínica, 2015
- Antimicrobial Activity of Ceftaroline Tested against Staphylococci with Reduced Susceptibility to Linezolid, Daptomycin, or Vancomycin from U.S. Hospitals, 2008 to 2011Antimicrobial Agents and Chemotherapy, 2013
- High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysisInternational Journal of Infectious Diseases, 2013
- Ceftaroline fosamil: a new broad-spectrum cephalosporinJournal of Antimicrobial Chemotherapy, 2011
- Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - comparison of pharmacology and clinical efficacyEuropean Journal of Medical Research, 2010
- Alternatives to Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus InfectionsClinical Infectious Diseases, 2007